Holdings (Monthly)
Guide ↗
ProShares Ultra Nasdaq Biotechnology
· ProShares Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 375558103 | Feb 2026 | 39,904 | $5.9M | 6.48% | EC |
| 2 | N/A | N/A | Feb 2026 | 4,291 | $5.8M | 6.34% | DE |
| 3 | Vertex Pharmaceuticals, Inc. | 92532F100 | Feb 2026 | 11,581 | $5.8M | 6.27% | EC |
| 4 | Amgen, Inc. | 031162100 | Feb 2026 | 14,536 | $5.6M | 6.15% | EC |
| 5 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Feb 2026 | 4,769 | $3.7M | 4.06% | EC |
| 6 | N/A | N/A | Feb 2026 | 2,484 | $3.3M | 3.61% | DE |
| 7 | N/A | N/A | Feb 2026 | 2,639 | $2.7M | 2.89% | DE |
| 8 | N/A | N/A | Feb 2026 | 6,179 | $2.6M | 2.85% | DE |
| 9 | N/A | N/A | Feb 2026 | 3,646 | $2.4M | 2.63% | DE |
| 10 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Feb 2026 | 6,101 | $2.0M | 2.21% | EC |
| 11 | INVESCO GOVT AND AGCY LEX | 825252885 | Feb 2026 | 1,662,868 | $1.7M | 1.81% | STIV |
| 12 | Repurchase Agreement | 000000000 | Feb 2026 | 1,567,851 | $1.6M | 1.71% | RA |
| 13 | Insmed, Inc. | 457669307 | Feb 2026 | 9,848 | $1.5M | 1.60% | EC |
| 14 | Biogen, Inc. | 09062X103 | Feb 2026 | 6,774 | $1.3M | 1.42% | EC |
| 15 | Argenx SE | 04016X101 | Feb 2026 | 1,344 | $1.0M | 1.12% | EC |
| 16 | United Therapeutics Corp. | 91307C102 | Feb 2026 | 1,988 | $1.0M | 1.09% | EC |
| 17 | Moderna, Inc. | 60770K107 | Feb 2026 | 18,039 | $966K | 1.05% | EC |
| 18 | Illumina, Inc. | 452327109 | Feb 2026 | 7,055 | $949K | 1.03% | EC |
| 19 | Roivant Sciences Ltd. | N/A | Feb 2026 | 32,114 | $929K | 1.01% | EC |
| 20 | Incyte Corp. | 45337C102 | Feb 2026 | 9,065 | $918K | 1.00% | EC |
| 21 | Royalty Pharma plc | N/A | Feb 2026 | 19,729 | $912K | 0.99% | EC |
| 22 | Revolution Medicines, Inc. | 76155X100 | Feb 2026 | 8,927 | $911K | 0.99% | EC |
| 23 | Viatris, Inc. | 92556V106 | Feb 2026 | 53,183 | $794K | 0.87% | EC |
| 24 | Repurchase Agreement | 000000000 | Feb 2026 | 776,976 | $777K | 0.85% | RA |
| 25 | Repurchase Agreement | 000000000 | Feb 2026 | 776,976 | $777K | 0.85% | RA |
| 26 | Ascendis Pharma A/S | 04351P101 | Feb 2026 | 2,835 | $662K | 0.72% | EC |
| 27 | Neurocrine Biosciences, Inc. | 64125C109 | Feb 2026 | 4,604 | $609K | 0.66% | EC |
| 28 | Ionis Pharmaceuticals, Inc. | 462222100 | Feb 2026 | 7,479 | $607K | 0.66% | EC |
| 29 | Sanofi SA | 80105N105 | Feb 2026 | 12,219 | $595K | 0.65% | EC |
| 30 | Bridgebio Pharma, Inc. | 10806X102 | Feb 2026 | 8,897 | $591K | 0.64% | EC |
| 31 | Medpace Holdings, Inc. | 58506Q109 | Feb 2026 | 1,301 | $588K | 0.64% | EC |
| 32 | Summit Therapeutics, Inc. | 86627T108 | Feb 2026 | 34,375 | $570K | 0.62% | EC |
| 33 | Guardant Health, Inc. | 40131M109 | Feb 2026 | 5,974 | $561K | 0.61% | EC |
| 34 | BioMarin Pharmaceutical, Inc. | 09061G101 | Feb 2026 | 8,871 | $548K | 0.60% | EC |
| 35 | Exelixis, Inc. | 30161Q104 | Feb 2026 | 12,381 | $546K | 0.59% | EC |
| 36 | Jazz Pharmaceuticals plc | N/A | Feb 2026 | 2,806 | $533K | 0.58% | EC |
| 37 | BioNTech SE | 09075V102 | Feb 2026 | 4,669 | $515K | 0.56% | EC |
| 38 | Repurchase Agreement | 000000000 | Feb 2026 | 466,185 | $466K | 0.51% | RA |
| 39 | Repurchase Agreement | 000000000 | Feb 2026 | 466,185 | $466K | 0.51% | RA |
| 40 | BeOne Medicines Ltd. | 07725L102 | Feb 2026 | 1,454 | $461K | 0.50% | EC |
| 41 | Madrigal Pharmaceuticals, Inc. | 558868105 | Feb 2026 | 1,048 | $453K | 0.49% | EC |
| 42 | ImmunityBio, Inc. | 45256X103 | Feb 2026 | 45,481 | $445K | 0.49% | EC |
| 43 | Tempus AI, Inc. | 88023B103 | Feb 2026 | 7,982 | $425K | 0.46% | EC |
| 44 | Arrowhead Pharmaceuticals, Inc. | 04280A100 | Feb 2026 | 6,271 | $397K | 0.43% | EC |
| 45 | Praxis Precision Medicines, Inc. | 74006W207 | Feb 2026 | 1,155 | $389K | 0.42% | EC |
| 46 | Repurchase Agreement | 000000000 | Feb 2026 | 388,488 | $388K | 0.42% | RA |
| 47 | Axsome Therapeutics, Inc. | 05464T104 | Feb 2026 | 2,327 | $381K | 0.42% | EC |
| 48 | Halozyme Therapeutics, Inc. | 40637H109 | Feb 2026 | 5,430 | $378K | 0.41% | EC |
| 49 | Vaxcyte, Inc. | 92243G108 | Feb 2026 | 6,044 | $373K | 0.41% | EC |
| 50 | Krystal Biotech, Inc. | 501147102 | Feb 2026 | 1,339 | $369K | 0.40% | EC |
| 51 | Cytokinetics, Inc. | 23282W605 | Feb 2026 | 5,646 | $351K | 0.38% | EC |
| 52 | Nuvalent, Inc. | 670703107 | Feb 2026 | 3,335 | $340K | 0.37% | EC |
| 53 | Abivax SA | 00370M103 | Feb 2026 | 2,726 | $331K | 0.36% | EC |
| 54 | Repurchase Agreement | 000000000 | Feb 2026 | 310,790 | $311K | 0.34% | RA |
| 55 | Repurchase Agreement | 000000000 | Feb 2026 | 310,790 | $311K | 0.34% | RA |
| 56 | Arcellx, Inc. | 03940C100 | Feb 2026 | 2,670 | $304K | 0.33% | EC |
| 57 | Kymera Therapeutics, Inc. | 501575104 | Feb 2026 | 3,322 | $303K | 0.33% | EC |
| 58 | Rhythm Pharmaceuticals, Inc. | 76243J105 | Feb 2026 | 3,082 | $286K | 0.31% | EC |
| 59 | Cogent Biosciences, Inc. | 19240Q201 | Feb 2026 | 7,088 | $275K | 0.30% | EC |
| 60 | Protagonist Therapeutics, Inc. | 74366E102 | Feb 2026 | 2,887 | $266K | 0.29% | EC |
| 61 | CRISPR Therapeutics AG | N/A | Feb 2026 | 4,400 | $265K | 0.29% | EC |
| 62 | Caris Life Sciences, Inc. | 142152107 | Feb 2026 | 13,029 | $262K | 0.29% | EC |
| 63 | PTC Therapeutics, Inc. | 69366J200 | Feb 2026 | 3,707 | $253K | 0.28% | EC |
| 64 | Alkermes plc | N/A | Feb 2026 | 7,624 | $229K | 0.25% | EC |
| 65 | Immunovant, Inc. | 45258J102 | Feb 2026 | 8,094 | $224K | 0.24% | EC |
| 66 | CG oncology, Inc. | 156944100 | Feb 2026 | 3,725 | $219K | 0.24% | EC |
| 67 | Mirum Pharmaceuticals, Inc. | 604749101 | Feb 2026 | 2,373 | $219K | 0.24% | EC |
| 68 | Scholar Rock Holding Corp. | 80706P103 | Feb 2026 | 4,710 | $209K | 0.23% | EC |
| 69 | Amicus Therapeutics, Inc. | 03152W109 | Feb 2026 | 14,247 | $205K | 0.22% | EC |
| 70 | Amneal Pharmaceuticals, Inc. | 03168L105 | Feb 2026 | 14,516 | $200K | 0.22% | EC |
| 71 | Structure Therapeutics, Inc. | 86366E106 | Feb 2026 | 3,086 | $194K | 0.21% | EC |
| 72 | ACADIA Pharmaceuticals, Inc. | 004225108 | Feb 2026 | 7,812 | $192K | 0.21% | EC |
| 73 | Indivior Pharmaceuticals, Inc. | 45579U109 | Feb 2026 | 5,763 | $189K | 0.21% | EC |
| 74 | Newamsterdam Pharma Co. NV | N/A | Feb 2026 | 5,236 | $186K | 0.20% | EC |
| 75 | Ligand Pharmaceuticals, Inc. | 53220K504 | Feb 2026 | 909 | $180K | 0.20% | EC |
| 76 | Crinetics Pharmaceuticals, Inc. | 22663K107 | Feb 2026 | 4,382 | $180K | 0.20% | EC |
| 77 | Erasca, Inc. | 29479A108 | Feb 2026 | 13,101 | $179K | 0.20% | EC |
| 78 | Apogee Therapeutics, Inc. | 03770N101 | Feb 2026 | 2,532 | $177K | 0.19% | EC |
| 79 | Terns Pharmaceuticals, Inc. | 880881107 | Feb 2026 | 4,160 | $175K | 0.19% | EC |
| 80 | ADMA Biologics, Inc. | 000899104 | Feb 2026 | 10,990 | $171K | 0.19% | EC |
| 81 | Repurchase Agreement | 000000000 | Feb 2026 | 155,395 | $155K | 0.17% | RA |
| 82 | Xenon Pharmaceuticals, Inc. | 98420N105 | Feb 2026 | 3,568 | $154K | 0.17% | EC |
| 83 | Spyre Therapeutics, Inc. | 00773J202 | Feb 2026 | 3,583 | $154K | 0.17% | EC |
| 84 | Arcutis Biotherapeutics, Inc. | 03969K108 | Feb 2026 | 5,656 | $153K | 0.17% | EC |
| 85 | Edgewise Therapeutics, Inc. | 28036F105 | Feb 2026 | 4,889 | $149K | 0.16% | EC |
| 86 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Feb 2026 | 1,961 | $148K | 0.16% | EC |
| 87 | Supernus Pharmaceuticals, Inc. | 868459108 | Feb 2026 | 2,648 | $145K | 0.16% | EC |
| 88 | Denali Therapeutics, Inc. | 24823R105 | Feb 2026 | 6,772 | $143K | 0.16% | EC |
| 89 | Veracyte, Inc. | 92337F107 | Feb 2026 | 3,650 | $134K | 0.15% | EC |
| 90 | Beam Therapeutics, Inc. | 07373V105 | Feb 2026 | 4,685 | $133K | 0.15% | EC |
| 91 | Alumis, Inc. | 022307102 | Feb 2026 | 4,489 | $133K | 0.15% | EC |
| 92 | Twist Bioscience Corp. | 90184D100 | Feb 2026 | 2,823 | $132K | 0.14% | EC |
| 93 | Ideaya Biosciences, Inc. | 45166A102 | Feb 2026 | 4,048 | $130K | 0.14% | EC |
| 94 | 10X Genomics, Inc. | 88025U109 | Feb 2026 | 5,379 | $124K | 0.14% | EC |
| 95 | Travere Therapeutics, Inc. | 89422G107 | Feb 2026 | 4,131 | $123K | 0.13% | EC |
| 96 | Apellis Pharmaceuticals, Inc. | 03753U106 | Feb 2026 | 5,839 | $122K | 0.13% | EC |
| 97 | Vera Therapeutics, Inc. | 92337R101 | Feb 2026 | 2,950 | $120K | 0.13% | EC |
| 98 | Centessa Pharmaceuticals plc | 152309100 | Feb 2026 | 4,455 | $120K | 0.13% | EC |
| 99 | Disc Medicine, Inc. | 254604101 | Feb 2026 | 1,744 | $116K | 0.13% | EC |
| 100 | Adaptive Biotechnologies Corp. | 00650F109 | Feb 2026 | 7,049 | $113K | 0.12% | EC |
| 101 | WaVe Life Sciences Ltd. | N/A | Feb 2026 | 7,723 | $108K | 0.12% | EC |
| 102 | Mineralys Therapeutics, Inc. | 603170101 | Feb 2026 | 3,654 | $107K | 0.12% | EC |
| 103 | Ultragenyx Pharmaceutical, Inc. | 90400D108 | Feb 2026 | 4,455 | $104K | 0.11% | EC |
| 104 | Dyne Therapeutics, Inc. | 26818M108 | Feb 2026 | 6,595 | $103K | 0.11% | EC |
| 105 | Maze Therapeutics, Inc. | 578784100 | Feb 2026 | 2,222 | $101K | 0.11% | EC |
| 106 | Stoke Therapeutics, Inc. | 86150R107 | Feb 2026 | 2,638 | $96K | 0.10% | EC |
| 107 | GRAIL, Inc. | 384747101 | Feb 2026 | 1,800 | $96K | 0.10% | EC |
| 108 | Kiniksa Pharmaceuticals International plc | N/A | Feb 2026 | 2,086 | $93K | 0.10% | EC |
| 109 | Harrow, Inc. | 415858109 | Feb 2026 | 1,710 | $93K | 0.10% | EC |
| 110 | Ocular Therapeutix, Inc. | 67576A100 | Feb 2026 | 9,837 | $88K | 0.10% | EC |
| 111 | Olema Pharmaceuticals, Inc. | 68062P106 | Feb 2026 | 3,632 | $88K | 0.10% | EC |
| 112 | Syndax Pharmaceuticals, Inc. | 87164F105 | Feb 2026 | 4,014 | $87K | 0.10% | EC |
| 113 | Recursion Pharmaceuticals, Inc. | 75629V104 | Feb 2026 | 23,743 | $87K | 0.10% | EC |
| 114 | Aurinia Pharmaceuticals, Inc. | 05156V102 | Feb 2026 | 6,088 | $86K | 0.09% | EC |
| 115 | BioCryst Pharmaceuticals, Inc. | 09058V103 | Feb 2026 | 9,722 | $85K | 0.09% | EC |
| 116 | Pharvaris NV | N/A | Feb 2026 | 2,958 | $84K | 0.09% | EC |
| 117 | Vericel Corp. | 92346J108 | Feb 2026 | 2,335 | $83K | 0.09% | EC |
| 118 | Relay Therapeutics, Inc. | 75943R102 | Feb 2026 | 8,003 | $82K | 0.09% | EC |
| 119 | Tyra Biosciences, Inc. | 90240B106 | Feb 2026 | 2,464 | $82K | 0.09% | EC |
| 120 | Enliven Therapeutics, Inc. | 29337E102 | Feb 2026 | 2,741 | $81K | 0.09% | EC |
| 121 | Agios Pharmaceuticals, Inc. | 00847X104 | Feb 2026 | 2,692 | $81K | 0.09% | EC |
| 122 | Sarepta Therapeutics, Inc. | 803607100 | Feb 2026 | 4,838 | $81K | 0.09% | EC |
| 123 | Zymeworks, Inc. | 98985Y108 | Feb 2026 | 3,456 | $80K | 0.09% | EC |
| 124 | Genmab A/S | 372303206 | Feb 2026 | 2,699 | $79K | 0.09% | EC |
| 125 | Definium Therapeutics, Inc. | 24477V105 | Feb 2026 | 4,548 | $79K | 0.09% | EC |
| 126 | Innoviva, Inc. | 45781M101 | Feb 2026 | 3,453 | $79K | 0.09% | EC |
| 127 | Oruka Therapeutics, Inc. | 687604108 | Feb 2026 | 2,236 | $77K | 0.08% | EC |
| 128 | Amylyx Pharmaceuticals, Inc. | 03237H101 | Feb 2026 | 5,071 | $77K | 0.08% | EC |
| 129 | ANI Pharmaceuticals, Inc. | 00182C103 | Feb 2026 | 1,037 | $77K | 0.08% | EC |
| 130 | Novavax, Inc. | 670002401 | Feb 2026 | 7,504 | $76K | 0.08% | EC |
| 131 | Harmony Biosciences Holdings, Inc. | 413197104 | Feb 2026 | 2,660 | $76K | 0.08% | EC |
| 132 | Sionna Therapeutics, Inc. | 829401108 | Feb 2026 | 2,061 | $75K | 0.08% | EC |
| 133 | Nurix Therapeutics, Inc. | 67080M103 | Feb 2026 | 4,680 | $75K | 0.08% | EC |
| 134 | RAPT Therapeutics, Inc. | 75382E208 | Feb 2026 | 1,279 | $74K | 0.08% | EC |
| 135 | Legend Biotech Corp. | 52490G102 | Feb 2026 | 3,888 | $74K | 0.08% | EC |
| 136 | Intellia Therapeutics, Inc. | 45826J105 | Feb 2026 | 5,348 | $74K | 0.08% | EC |
| 137 | Ardelyx, Inc. | 039697107 | Feb 2026 | 11,220 | $73K | 0.08% | EC |
| 138 | Iovance Biotherapeutics, Inc. | 462260100 | Feb 2026 | 18,330 | $71K | 0.08% | EC |
| 139 | Novocure Ltd. | N/A | Feb 2026 | 5,171 | $71K | 0.08% | EC |
| 140 | Trevi Therapeutics, Inc. | 89532M101 | Feb 2026 | 5,921 | $71K | 0.08% | EC |
| 141 | AnaptysBio, Inc. | 032724106 | Feb 2026 | 1,278 | $70K | 0.08% | EC |
| 142 | Tango Therapeutics, Inc. | 87583X109 | Feb 2026 | 6,219 | $69K | 0.08% | EC |
| 143 | MBX Biosciences, Inc. | 55287L101 | Feb 2026 | 2,073 | $67K | 0.07% | EC |
| 144 | EyePoint, Inc. | 30233G209 | Feb 2026 | 3,822 | $67K | 0.07% | EC |
| 145 | Kodiak Sciences, Inc. | 50015M109 | Feb 2026 | 2,450 | $66K | 0.07% | EC |
| 146 | Zenas Biopharma, Inc. | 98937L105 | Feb 2026 | 2,478 | $65K | 0.07% | EC |
| 147 | Immunocore Holdings plc | 45258D105 | Feb 2026 | 2,015 | $65K | 0.07% | EC |
| 148 | Rapport Therapeutics, Inc. | 75383L102 | Feb 2026 | 2,201 | $64K | 0.07% | EC |
| 149 | Corvus Pharmaceuticals, Inc. | 221015100 | Feb 2026 | 3,449 | $63K | 0.07% | EC |
| 150 | Precigen, Inc. | 74017N105 | Feb 2026 | 16,338 | $62K | 0.07% | EC |
| 151 | AtaiBeckley, Inc. | 04650F101 | Feb 2026 | 16,770 | $61K | 0.07% | EC |
| 152 | Collegium Pharmaceutical, Inc. | 19459J104 | Feb 2026 | 1,460 | $61K | 0.07% | EC |
| 153 | ORIC Pharmaceuticals, Inc. | 68622P109 | Feb 2026 | 4,497 | $60K | 0.07% | EC |
| 154 | Septerna, Inc. | 81734D104 | Feb 2026 | 2,067 | $60K | 0.07% | EC |
| 155 | Vir Biotechnology, Inc. | 92764N102 | Feb 2026 | 6,424 | $58K | 0.06% | EC |
| 156 | Alvotech SA | N/A | Feb 2026 | 14,454 | $58K | 0.06% | EC |
| 157 | Taysha Gene Therapies, Inc. | 877619106 | Feb 2026 | 12,648 | $57K | 0.06% | EC |
| 158 | Savara, Inc. | 805111101 | Feb 2026 | 9,395 | $57K | 0.06% | EC |
| 159 | Monte Rosa Therapeutics, Inc. | 61225M102 | Feb 2026 | 3,007 | $53K | 0.06% | EC |
| 160 | Sana Biotechnology, Inc. | 799566104 | Feb 2026 | 12,300 | $52K | 0.06% | EC |
| 161 | Phibro Animal Health Corp. | 71742Q106 | Feb 2026 | 946 | $52K | 0.06% | EC |
| 162 | Grifols SA | 398438408 | Feb 2026 | 5,633 | $51K | 0.06% | EC |
| 163 | Day One Biopharmaceuticals, Inc. | 23954D109 | Feb 2026 | 4,741 | $50K | 0.05% | EC |
| 164 | AbCellera Biologics, Inc. | 00288U106 | Feb 2026 | 13,822 | $50K | 0.05% | EC |
| 165 | Inhibrx Biosciences, Inc. | 45720N103 | Feb 2026 | 672 | $50K | 0.05% | EC |
| 166 | Geron Corp. | 374163103 | Feb 2026 | 29,476 | $50K | 0.05% | EC |
| 167 | UroGen Pharma Ltd. | N/A | Feb 2026 | 2,162 | $47K | 0.05% | EC |
| 168 | Xeris Biopharma Holdings, Inc. | 98422E103 | Feb 2026 | 7,662 | $47K | 0.05% | EC |
| 169 | MannKind Corp. | 56400P706 | Feb 2026 | 14,180 | $47K | 0.05% | EC |
| 170 | Ventyx Biosciences, Inc. | 92332V107 | Feb 2026 | 3,295 | $46K | 0.05% | EC |
| 171 | Fortrea Holdings, Inc. | 34965K107 | Feb 2026 | 4,266 | $46K | 0.05% | EC |
| 172 | uniQure NV | N/A | Feb 2026 | 2,877 | $45K | 0.05% | EC |
| 173 | ArriVent Biopharma, Inc. | 04272N102 | Feb 2026 | 1,906 | $44K | 0.05% | EC |
| 174 | Pacira BioSciences, Inc. | 695127100 | Feb 2026 | 1,986 | $44K | 0.05% | EC |
| 175 | Amphastar Pharmaceuticals, Inc. | 03209R103 | Feb 2026 | 2,122 | $43K | 0.05% | EC |
| 176 | Theravance Biopharma, Inc. | N/A | Feb 2026 | 2,340 | $43K | 0.05% | EC |
| 177 | GH Research plc | N/A | Feb 2026 | 2,864 | $43K | 0.05% | EC |
| 178 | Bicara Therapeutics, Inc. | 055477103 | Feb 2026 | 2,530 | $42K | 0.05% | EC |
| 179 | ARS Pharmaceuticals, Inc. | 82835W108 | Feb 2026 | 4,564 | $42K | 0.05% | EC |
| 180 | Cullinan Therapeutics, Inc. | 230031106 | Feb 2026 | 2,728 | $42K | 0.05% | EC |
| 181 | Xencor, Inc. | 98401F105 | Feb 2026 | 3,298 | $42K | 0.05% | EC |
| 182 | CytomX Therapeutics, Inc. | 23284F105 | Feb 2026 | 7,823 | $42K | 0.05% | EC |
| 183 | Arbutus Biopharma Corp. | 03879J100 | Feb 2026 | 8,881 | $41K | 0.05% | EC |
| 184 | Phathom Pharmaceuticals, Inc. | 71722W107 | Feb 2026 | 3,285 | $41K | 0.04% | EC |
| 185 | Castle Biosciences, Inc. | 14843C105 | Feb 2026 | 1,348 | $40K | 0.04% | EC |
| 186 | Omeros Corp. | 682143102 | Feb 2026 | 3,274 | $39K | 0.04% | EC |
| 187 | Arvinas, Inc. | 04335A105 | Feb 2026 | 2,965 | $39K | 0.04% | EC |
| 188 | Prime Medicine, Inc. | 74168J101 | Feb 2026 | 8,335 | $39K | 0.04% | EC |
| 189 | KalVista Pharmaceuticals, Inc. | 483497103 | Feb 2026 | 2,334 | $38K | 0.04% | EC |
| 190 | Janux Therapeutics, Inc. | 47103J105 | Feb 2026 | 2,777 | $38K | 0.04% | EC |
| 191 | Annexon, Inc. | 03589W102 | Feb 2026 | 6,683 | $37K | 0.04% | EC |
| 192 | Personalis, Inc. | 71535D106 | Feb 2026 | 4,101 | $37K | 0.04% | EC |
| 193 | Esperion Therapeutics, Inc. | 29664W105 | Feb 2026 | 11,038 | $37K | 0.04% | EC |
| 194 | BioAge Labs, Inc. | 09077V100 | Feb 2026 | 1,656 | $37K | 0.04% | EC |
| 195 | Mesoblast Ltd. | 590717401 | Feb 2026 | 2,264 | $36K | 0.04% | EC |
| 196 | Kura Oncology, Inc. | 50127T109 | Feb 2026 | 4,018 | $35K | 0.04% | EC |
| 197 | Zai Lab Ltd. | 98887Q104 | Feb 2026 | 1,808 | $35K | 0.04% | EC |
| 198 | Compass Pathways plc | 20451W101 | Feb 2026 | 4,351 | $30K | 0.03% | EC |
| 199 | Rigel Pharmaceuticals, Inc. | 766559702 | Feb 2026 | 838 | $29K | 0.03% | EC |
| 200 | Allogene Therapeutics, Inc. | 019770106 | Feb 2026 | 10,377 | $29K | 0.03% | EC |
| 201 | MeiraGTx Holdings plc | N/A | Feb 2026 | 3,717 | $28K | 0.03% | EC |
| 202 | Replimune Group, Inc. | 76029N106 | Feb 2026 | 3,622 | $28K | 0.03% | EC |
| 203 | Design Therapeutics, Inc. | 25056L103 | Feb 2026 | 2,630 | $27K | 0.03% | EC |
| 204 | Neumora Therapeutics, Inc. | 640979100 | Feb 2026 | 7,715 | $27K | 0.03% | EC |
| 205 | CorMedix, Inc. | 21900C308 | Feb 2026 | 3,638 | $26K | 0.03% | EC |
| 206 | Ironwood Pharmaceuticals, Inc. | 46333X108 | Feb 2026 | 7,512 | $26K | 0.03% | EC |
| 207 | 4D Molecular Therapeutics, Inc. | 35104E100 | Feb 2026 | 2,638 | $25K | 0.03% | EC |
| 208 | Rocket Pharmaceuticals, Inc. | 77313F106 | Feb 2026 | 4,990 | $25K | 0.03% | EC |
| 209 | Vanda Pharmaceuticals, Inc. | 921659108 | Feb 2026 | 2,729 | $24K | 0.03% | EC |
| 210 | Lexeo Therapeutics, Inc. | 52886X107 | Feb 2026 | 3,370 | $24K | 0.03% | EC |
| 211 | Maravai LifeSciences Holdings, Inc. | 56600D107 | Feb 2026 | 6,696 | $24K | 0.03% | EC |
| 212 | Lyell Immunopharma, Inc. | 55083R203 | Feb 2026 | 979 | $23K | 0.03% | EC |
| 213 | Pacific Biosciences of California, Inc. | 69404D108 | Feb 2026 | 13,941 | $23K | 0.03% | EC |
| 214 | Zevra Therapeutics, Inc. | 488445206 | Feb 2026 | 2,600 | $23K | 0.03% | EC |
| 215 | Kamada Ltd. | N/A | Feb 2026 | 2,664 | $23K | 0.03% | EC |
| 216 | Aquestive Therapeutics, Inc. | 03843E104 | Feb 2026 | 5,633 | $23K | 0.02% | EC |
| 217 | Galapagos NV | 36315X101 | Feb 2026 | 668 | $22K | 0.02% | EC |
| 218 | Solid Biosciences, Inc. | 83422E204 | Feb 2026 | 3,598 | $22K | 0.02% | EC |
| 219 | Invivyd, Inc. | 00534A102 | Feb 2026 | 12,796 | $22K | 0.02% | EC |
| 220 | Prothena Corp. plc | N/A | Feb 2026 | 2,485 | $22K | 0.02% | EC |
| 221 | SIGA Technologies, Inc. | 826917106 | Feb 2026 | 3,307 | $21K | 0.02% | EC |
| 222 | REGENXBIO, Inc. | 75901B107 | Feb 2026 | 2,337 | $21K | 0.02% | EC |
| 223 | Entrada Therapeutics, Inc. | 29384C108 | Feb 2026 | 1,765 | $21K | 0.02% | EC |
| 224 | Eton Pharmaceuticals, Inc. | 29772L108 | Feb 2026 | 1,239 | $21K | 0.02% | EC |
| 225 | Larimar Therapeutics, Inc. | 517125100 | Feb 2026 | 3,953 | $21K | 0.02% | EC |
| 226 | Fulcrum Therapeutics, Inc. | 359616109 | Feb 2026 | 2,499 | $21K | 0.02% | EC |
| 227 | Altimmune, Inc. | 02155H200 | Feb 2026 | 4,819 | $21K | 0.02% | EC |
| 228 | Tectonic Therapeutic, Inc. | 878972108 | Feb 2026 | 864 | $20K | 0.02% | EC |
| 229 | Keros Therapeutics, Inc. | 492327101 | Feb 2026 | 1,406 | $20K | 0.02% | EC |
| 230 | PepGen, Inc. | 713317105 | Feb 2026 | 3,175 | $20K | 0.02% | EC |
| 231 | LENZ Therapeutics, Inc. | 52635N103 | Feb 2026 | 1,445 | $19K | 0.02% | EC |
| 232 | Upstream Bio, Inc. | 91678A107 | Feb 2026 | 2,495 | $19K | 0.02% | EC |
| 233 | Enanta Pharmaceuticals, Inc. | 29251M106 | Feb 2026 | 1,332 | $19K | 0.02% | EC |
| 234 | Absci Corp. | 00091E109 | Feb 2026 | 6,944 | $19K | 0.02% | EC |
| 235 | Anavex Life Sciences Corp. | 032797300 | Feb 2026 | 4,125 | $18K | 0.02% | EC |
| 236 | Aura Biosciences, Inc. | 05153U107 | Feb 2026 | 2,932 | $17K | 0.02% | EC |
| 237 | Atea Pharmaceuticals, Inc. | 04683R106 | Feb 2026 | 3,607 | $17K | 0.02% | EC |
| 238 | Neurogene, Inc. | 64135M105 | Feb 2026 | 715 | $17K | 0.02% | EC |
| 239 | Kyverna Therapeutics, Inc. | 501976104 | Feb 2026 | 2,023 | $17K | 0.02% | EC |
| 240 | Contineum Therapeutics, Inc. | 21217B100 | Feb 2026 | 1,067 | $16K | 0.02% | EC |
| 241 | Autolus Therapeutics plc | 05280R100 | Feb 2026 | 9,262 | $16K | 0.02% | EC |
| 242 | NovaBridge Biosciences | 44975P103 | Feb 2026 | 4,801 | $16K | 0.02% | EC |
| 243 | Immuneering Corp. | 45254E107 | Feb 2026 | 2,981 | $15K | 0.02% | EC |
| 244 | Foghorn Therapeutics, Inc. | 344174107 | Feb 2026 | 2,611 | $15K | 0.02% | EC |
| 245 | Cabaletta Bio, Inc. | 12674W109 | Feb 2026 | 4,445 | $15K | 0.02% | EC |
| 246 | Aclaris Therapeutics, Inc. | 00461U105 | Feb 2026 | 5,003 | $14K | 0.02% | EC |
| 247 | AC Immune SA | N/A | Feb 2026 | 4,636 | $14K | 0.01% | EC |
| 248 | Candel Therapeutics, Inc. | 137404109 | Feb 2026 | 2,535 | $13K | 0.01% | EC |
| 249 | Puma Biotechnology, Inc. | 74587V107 | Feb 2026 | 2,326 | $13K | 0.01% | EC |
| 250 | Evolus, Inc. | 30052C107 | Feb 2026 | 2,993 | $13K | 0.01% | EC |
| 251 | Aardvark Therapeutics, Inc. | 002942100 | Feb 2026 | 1,005 | $13K | 0.01% | EC |
| 252 | Lifecore Biomedical, Inc. | 514766104 | Feb 2026 | 1,730 | $12K | 0.01% | EC |
| 253 | Bicycle Therapeutics plc | 088786108 | Feb 2026 | 2,136 | $12K | 0.01% | EC |
| 254 | C4 Therapeutics, Inc. | 12529R107 | Feb 2026 | 4,475 | $12K | 0.01% | EC |
| 255 | Vor BioPharma, Inc. | 929033207 | Feb 2026 | 778 | $12K | 0.01% | EC |
| 256 | Silence Therapeutics plc | 82686Q101 | Feb 2026 | 2,169 | $12K | 0.01% | EC |
| 257 | OmniAb, Inc. | 68218J103 | Feb 2026 | 6,647 | $11K | 0.01% | EC |
| 258 | Orchestra BioMed Holdings, Inc. | 68572M106 | Feb 2026 | 2,607 | $11K | 0.01% | EC |
| 259 | Voyager Therapeutics, Inc. | 92915B106 | Feb 2026 | 2,721 | $11K | 0.01% | EC |
| 260 | Arcturus Therapeutics Holdings, Inc. | 03969T109 | Feb 2026 | 1,312 | $11K | 0.01% | EC |
| 261 | Editas Medicine, Inc. | 28106W103 | Feb 2026 | 4,508 | $10K | 0.01% | EC |
| 262 | Humacyte, Inc. | 44486Q103 | Feb 2026 | 8,647 | $10K | 0.01% | EC |
| 263 | Coherus Oncology, Inc. | 19249H103 | Feb 2026 | 5,581 | $9K | 0.01% | EC |
| 264 | Quantum-Si, Inc. | 74765K105 | Feb 2026 | 9,030 | $9K | 0.01% | EC |
| 265 | Caribou Biosciences, Inc. | 142038108 | Feb 2026 | 4,316 | $8K | 0.01% | EC |
| 266 | Sagimet Biosciences, Inc. | 786700104 | Feb 2026 | 1,432 | $8K | 0.01% | EC |
| 267 | Jyong Biotech Ltd. | N/A | Feb 2026 | 3,511 | $8K | 0.01% | EC |
| 268 | Black Diamond Therapeutics, Inc. | 09203E105 | Feb 2026 | 2,631 | $6K | 0.01% | EC |
| 269 | Alpha Teknova, Inc. | 02080L102 | Feb 2026 | 2,471 | $6K | 0.01% | EC |
| 270 | Rani Therapeutics Holdings, Inc. | 753018100 | Feb 2026 | 4,504 | $6K | 0.01% | EC |
| 271 | Gossamer Bio, Inc. | 38341P102 | Feb 2026 | 10,687 | $5K | 0.00% | EC |
| 272 | Tenaya Therapeutics, Inc. | 87990A106 | Feb 2026 | 7,688 | $4K | 0.00% | EC |
| 273 | Pyxis Oncology, Inc. | 747324101 | Feb 2026 | 2,875 | $4K | 0.00% | EC |
| 274 | Codexis, Inc. | 192005106 | Feb 2026 | 4,171 | $4K | 0.00% | EC |
| 275 | Sutro Biopharma, Inc. | 869367201 | Feb 2026 | 1 | $20 | 0.00% | EC |
| 276 | Cartesian Therapeutics, Inc. | 816212112 | Feb 2026 | 9,785 | $0 | 0.00% | — |
| 277 | Third Harmonic Bio, Inc. | 88427A107 | Feb 2026 | 1,662 | $0 | 0.00% | EC |
| 278 | N/A | N/A | Feb 2026 | 633 | $-1662821 | -1.81% | DE |